Medical News

RSS

RayStation treatment planning system receives FDA marketing clearance

RaySearch Laboratories AB has received FDA 510(k) clearance for its RayStation® treatment planning system.

17 Mar 2010

Hikma Pharmaceuticals announces 36% increase in operating profits for 2009

Hikma Pharmaceuticals today announced 2009 preliminary results with operating profits up 36% on the back of a strong performance from its Middle East markets.

17 Mar 2010

Can preventative vaccines curb the rising numbers of HIV cases?

According to a recent United Nations study, HIV infection rates among high-risk groups such as gays, drug users and sex workers are on the rise around the world.

17 Mar 2010

Reversal of aging in normal human cells

BioTime, Inc., a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, today announced the publication of a scientific paper titled “Spontaneous Reversal of Developmental Aging in Normal Human Cells Following Transcriptional Reprogramming.”

17 Mar 2010

Electronic cigarettes revolutionize the face of tobacco smoking

The new face of tobacco smoking has now become vaping due to the increasing popularity of the electronic cigarette. This product was so revolutionary that even pharmaceutical industry reports stated that "e-cigarettes will revolutionize the face of tobacco smoking and could pose a threat to the smoking cessation market."

17 Mar 2010

Patients with chronic conditions need support to re-enter employment

A new study has identified a significant shortfall in patients with life-long but treatable conditions re-entering employment. The research is being presented at the annual Society for Endocrinology BES meeting in Manchester.

17 Mar 2010

Sonic Innovations' moisture-resistant hearing aids outlast competition

Sonic Innovations, the U.S.-based hearing aid manufacturer, recently conducted moisture-resistance tests using two of its products and eight from major competitors. The results? Sonic outlasted its nearest competitor by 44 percent.

17 Mar 2010

Most controversial issues in urology to be discussed in the Annual Congress of EAU

Some of the most controversial issues in urology will be discussed by leading experts during the five-day 25th Annual Congress of the European Association of Urology in the Fira Barcelona congress venue in Barcelona (ES). From April 16 to 20, close to 12,000 participants and 3,000 company representatives are expected to gather in one of the world's biggest annual professional meetings in urology.

17 Mar 2010

Restoring immune function in HIV patients: Therapies targeting PD-1 and IL-10 molecules needed

New research conducted by the scientific director for VGTI Florida and his colleagues at the University of Montreal, in collaboration with scientists from the NIH and the McGill University Hospital center, may soon lead to an expansion of the drug arsenal used to fight HIV. The research sheds new light on how HIV gradually weakens the body’s immune system and highlights the need for new research into therapies that will target the chain of events that cause the progression of the disease.

17 Mar 2010

Case management funds breast cancer screening and diagnostic services for low-income women

Case management appears to be associated with more appropriate follow-up and shorter time to diagnostic resolution among low-income women who receive an abnormal result on a mammogram, according to a report in the March 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

17 Mar 2010

Avid Bioservices highlights data of single-use bioreactors and traditional stainless steel bioreactors

Avid Bioservices, Inc. today presented data highlighting the comparability of production run performance between the company's single-use bioreactors (Thermo Scientific HyClone S.U.B.) and its traditional stainless steel bioreactors at the Thermo Scientific BioProduction Optimization Workshop in San Francisco, California.

From Thermo Fisher Scientific Inc. 17 Mar 2010

Compugen announces validation of IDD discovery platform for identification of cell penetrating peptides

Compugen Ltd. announced today the development and validation of its Intracellular Drug Delivery (IDD) discovery platform for identification of cell penetrating peptides. Compugen also announced that as part of the validation process for the new platform, more than twenty novel peptides, predicted and selected in silico, demonstrated the predicted cell penetrating properties in initial experimental validation studies.

17 Mar 2010

'Quiet corruption' impedes African development, World Bank report says

What the World Bank has dubbed "quiet corruption" in it's Africa Development Indicators 2010 report (.pdf) could be as significant a threat to the continent's development "as the graft scandals that frequently dominate newspaper headlines," Bloomberg/BusinessWeek reports (McGregor/Seria, 3/15).

17 Mar 2010

Researchers identify a novel way to study species-specific reproductive behavior

Researchers at the California Institute of Technology (Caltech) and the University of California, San Diego (UCSD) have discovered that injecting a simple hormone into leeches creates a novel way to study how hormones and the nervous system work together to produce species-specific reproductive behavior.

17 Mar 2010

TSO3's STERIZONE Sterilization System exhibited under 3M brand at AORN Annual Congress

TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings using ozone, announced today that its new generation STERIZONE(R) Sterilization System, is being exhibited in the 3M(TM)booth under the 3M(TM) brand Optreoz(TM)125-Z Sterilizer at the Association of Perioperative Registered Nurses 57th Annual Congress held from March 13 to 18 in Denver, Colorado.

17 Mar 2010

Neovasc Reducer three-year follow-up data presented at 2010 ACC annual meeting

Neovasc Inc., a developer of novel technologies used to treat vascular disease, today presented results from the follow-up phase of the initial clinical trial of its Neovasc Reducer(TM) product at the American College of Cardiology 2010 annual meeting. The Neovasc Reducer is a novel implantable product designed to treat heart disease patients who suffer from refractory angina. The new data shows that three years after implantation of the Reducer, the majority of patients continued to show measurable improvement in angina symptoms.

17 Mar 2010

Nasal washes may help reduce sinus infection

Washing out your nose with a spray or spout of salt water is safe and might even get you back to work sooner after a cold or acute sinus infection. However, there is not enough evidence to show that it can reduce your symptoms significantly, according to a new research review.

17 Mar 2010

Unapproved drugs: National Minority Quality Forum launches new public information campaign

The National Minority Quality Forum (The Forum) is launching a new public information campaign aimed to help educate consumers, physicians, and policymakers about the risks associated with prescribing and taking unapproved drugs that have not been subjected to the rigorous Food and Drug Administration’s (FDA) review and approval process.

17 Mar 2010

Health science professor urges institutions to establish zero tolerance policy to prevent workplace violence

When health care organizations don't establish effective measures to prevent violence and protect nurses, the result is compromised quality of care for patients. Establishing a zero tolerance policy for violence is the first step, according to Jean Henry, a health science researcher at the University of Arkansas.

17 Mar 2010

HCRS selected to provide IT support services for three states

HealthCare Resolution Services, Inc. (HCRS), a leading provider of program integrity support, health information technology (IT) services and professional medical and technical staffing, announced today that it has been accepted as a subcontractor for three contract vehicles serving the states of Maryland, Texas, and Florida.

17 Mar 2010

Medical News

RayStation treatment planning system receives FDA marketing clearance

Hikma Pharmaceuticals announces 36% increase in operating profits for 2009

Can preventative vaccines curb the rising numbers of HIV cases?

Reversal of aging in normal human cells

Electronic cigarettes revolutionize the face of tobacco smoking

Patients with chronic conditions need support to re-enter employment

Sonic Innovations' moisture-resistant hearing aids outlast competition

Most controversial issues in urology to be discussed in the Annual Congress of EAU

Restoring immune function in HIV patients: Therapies targeting PD-1 and IL-10 molecules needed

Case management funds breast cancer screening and diagnostic services for low-income women

Avid Bioservices highlights data of single-use bioreactors and traditional stainless steel bioreactors

Compugen announces validation of IDD discovery platform for identification of cell penetrating peptides

'Quiet corruption' impedes African development, World Bank report says

Researchers identify a novel way to study species-specific reproductive behavior

TSO3's STERIZONE Sterilization System exhibited under 3M brand at AORN Annual Congress

Neovasc Reducer three-year follow-up data presented at 2010 ACC annual meeting

Nasal washes may help reduce sinus infection

Unapproved drugs: National Minority Quality Forum launches new public information campaign

Health science professor urges institutions to establish zero tolerance policy to prevent workplace violence

HCRS selected to provide IT support services for three states

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Latest News